- Investing Ideas
- Italian Pharmaceuticals & Biotech Pure Equity Growth
Italian Pharmaceuticals & Biotech Pure Equity Growth
Results
2
0 new
Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.
2 companies
Krystal Biotech
Market Cap: €9.6b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
1KRYS
€278.10
7D
5.9%
1Y
145.3%
Corcept Therapeutics
Market Cap: €8.9b
A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
1CORT
€72.32
7D
11.2%
1Y
15.8%